Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 312

1.

Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer.

Benešová M, Schäfer M, Bauder-Wüst U, Afshar-Oromieh A, Kratochwil C, Mier W, Haberkorn U, Kopka K, Eder M.

J Nucl Med. 2015 Apr 16. pii: jnumed.114.147413. [Epub ahead of print]

PMID:
25883127
2.

18F-FDG Dynamic PET/CT in Patients with Multiple Myeloma: Patterns of Tracer Uptake and Correlation With Bone Marrow Plasma Cell Infiltration Rate.

Sachpekidis C, Mai EK, Goldschmidt H, Hillengass J, Hose D, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A.

Clin Nucl Med. 2015 Mar 17. [Epub ahead of print]

PMID:
25783508
3.

Cancer stratification by molecular imaging.

Weber J, Haberkorn U, Mier W.

Int J Mol Sci. 2015 Mar 4;16(3):4918-46. doi: 10.3390/ijms16034918. Review.

4.

PMPA for nephroprotection in PSMA-targeted radionuclide therapy of prostate cancer.

Kratochwil C, Giesel FL, Leotta K, Eder M, Hoppe-Tich T, Youssoufian H, Kopka K, Babich JW, Haberkorn U.

J Nucl Med. 2015 Feb;56(2):293-8. doi: 10.2967/jnumed.114.147181. Epub 2015 Jan 22.

PMID:
25613537
5.

Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.

Schölch S, Rauber C, Tietz A, Rahbari NN, Bork U, Schmidt T, Kahlert C, Haberkorn U, Tomai MA, Lipson KE, Carretero R, Weitz J, Koch M, Huber PE.

Oncotarget. 2015 Mar 10;6(7):4663-76.

6.

[(177)Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.

Kratochwil C, Giesel FL, Eder M, Afshar-Oromieh A, Benešová M, Mier W, Kopka K, Haberkorn U.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):987-8. doi: 10.1007/s00259-014-2978-1. Epub 2015 Jan 9. No abstract available.

PMID:
25573634
7.

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, Eisenhut M, Boxler S, Hadaschik BA, Kratochwil C, Weichert W, Kopka K, Debus J, Haberkorn U.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209. doi: 10.1007/s00259-014-2949-6. Epub 2014 Nov 20.

8.

Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.

Sachpekidis C, Larribere L, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A, Hassel JC.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):386-96. doi: 10.1007/s00259-014-2944-y. Epub 2014 Oct 31.

PMID:
25359635
9.

SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.

Kratochwil C, Stefanova M, Mavriopoulou E, Holland-Letz T, Dimitrakopoulou-Strauss A, Afshar-Oromieh A, Mier W, Haberkorn U, Giesel FL.

Mol Imaging Biol. 2014 Oct 16. [Epub ahead of print]

PMID:
25319765
10.

Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.

Mickan A, Sarko D, Haberkorn U, Mier W.

Curr Pharm Biotechnol. 2014;15(3):200-9.

PMID:
25312539
11.

Radionuclides in drug development.

Uhl P, Fricker G, Haberkorn U, Mier W.

Drug Discov Today. 2015 Feb;20(2):198-208. doi: 10.1016/j.drudis.2014.09.027. Epub 2014 Oct 7. Review.

PMID:
25304182
12.

Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT.

Doberstein K, Harter PN, Haberkorn U, Bretz NP, Arnold B, Carretero R, Moldenhauer G, Mittelbronn M, Altevogt P.

Int J Cancer. 2015 Mar 1;136(5):E326-39. doi: 10.1002/ijc.29222. Epub 2014 Sep 25.

PMID:
25230579
13.

Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling.

Lehmann LH, Rostosky JS, Buss SJ, Kreusser MM, Krebs J, Mier W, Enseleit F, Spiger K, Hardt SE, Wieland T, Haass M, Lüscher TF, Schneider MD, Parlato R, Gröne HJ, Haberkorn U, Yanagisawa M, Katus HA, Backs J.

Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13499-504. doi: 10.1073/pnas.1409026111. Epub 2014 Sep 2.

14.

²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience.

Kratochwil C, Giesel FL, Bruchertseifer F, Mier W, Apostolidis C, Boll R, Murphy K, Haberkorn U, Morgenstern A.

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2106-19. doi: 10.1007/s00259-014-2857-9. Epub 2014 Jul 29.

PMID:
25070685
15.

Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.

Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, Rückert F, Zach S, Haberkorn U, Gross W, Schönsiegel F, Bazhin AV, Herr I.

Oncotarget. 2014 Jul 15;5(13):5177-89.

16.

Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.

Afshar-Oromieh A, Wolf MB, Kratochwil C, Giesel FL, Combs SE, Dimitrakopoulou-Strauss A, Gnirs R, Roethke MC, Schlemmer HP, Haberkorn U.

Neuro Oncol. 2015 Feb;17(2):312-9. doi: 10.1093/neuonc/nou131. Epub 2014 Jul 9.

PMID:
25008094
17.

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.

Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K.

Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779.

18.

Current status in the therapy of liver diseases.

Uhl P, Fricker G, Haberkorn U, Mier W.

Int J Mol Sci. 2014 Apr 30;15(5):7500-12. doi: 10.3390/ijms15057500. Review.

19.

Noninvasive risk stratification of patients with transthyretin amyloidosis.

Kristen AV, Scherer K, Buss S, aus dem Siepen F, Haufe S, Bauer R, Hinderhofer K, Giannitsis E, Hardt S, Haberkorn U, Katus HA, Steen H.

JACC Cardiovasc Imaging. 2014 May;7(5):502-10. doi: 10.1016/j.jcmg.2014.03.002. Epub 2014 Apr 9.

PMID:
24726252
20.

Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies.

Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blöcker IM, Bahtz R, Komorowski L, Stöcker W, Kastrup A, Kuthe M, Meinck HM.

Neurology. 2014 Apr 29;82(17):1521-8. doi: 10.1212/WNL.0000000000000372. Epub 2014 Apr 2.

PMID:
24696508
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk